StockWatch
·
Pharmaceuticals
Management Change27 Apr 2026, 08:13 pm

Kimia Biosciences Appoints Mani Jain as CFO & KMP

AI Summary

Kimia Biosciences Ltd has announced the appointment of Mr. Mani Jain as its new Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective April 27, 2026. The Board of Directors approved this appointment at their meeting held on the same date. Mr. Jain brings over 28 years of extensive experience in finance, accounts, treasury, budgeting, taxation, audits, and strategic financial management. His background includes senior leadership roles, fundraising, project finance, internal controls, and statutory compliances. The company confirmed that Mr. Jain is not related to any existing director and is not debarred by any regulatory authority.

Key Highlights

  • Kimia Biosciences appointed Mr. Mani Jain as CFO and KMP.
  • Appointment is effective from April 27, 2026.
  • Mr. Jain has over 28 years of experience in finance.
  • He is a qualified Chartered Accountant with leadership experience.
  • No relation to existing directors; not debarred by SEBI.